Brain fuel mystery: could glucagon be the key?
NCT ID NCT07350512
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study will test how the hormone glucagon affects brain function and sugar metabolism in 15 healthy adults. Participants receive an intravenous infusion of alanine, which triggers glucagon release, while researchers measure changes in blood sugar and other markers. The goal is to understand glucagon's role in the brain, which could lead to new insights into metabolic and cognitive health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
alanine
What this could lead to
If successful, this could reveal how glucagon influences brain energy use and thinking, possibly pointing to new ways to treat metabolic or cognitive disorders.
What could go wrong
This is a very early, small pilot study in healthy people, so results may not apply to patients. It only looks at short-term effects, not long-term benefits or risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLUCOSE METABOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg
Copenhagen, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••